NUVB: Nuvation Bio Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 720.46
Enterprise Value ($M) 675.25
Book Value ($M) 419.46
Book Value / Share 1.24
Price / Book 1.71
NCAV ($M) 402.54
NCAV / Share 1.18
Price / NCAV 1.79

Profitability (mra)
Return on Invested Capital (ROIC) -1.41
Return on Assets (ROA) -0.99
Return on Equity (ROE) -1.02

Liquidity (mrq)
Quick Ratio 9.01
Current Ratio 9.01

Balance Sheet (mrq) ($M)
Current Assets 475.57
Assets 492.49
Liabilities 73.03
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 7.87
Operating Income -167.56
Net Income -567.94
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -130.41
Cash from Investing 122.70
Cash from Financing 0.33

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
05-12 13G/A Fmr Llc 15.00 11.73
04-28 13G/A BlackRock, Inc. 4.90 27.62
10-18 13D/A Omega Fund V, L.P. 3.90 -13.27
09-10 13D Decheng Capital China Life Sciences USD Fund III, L.P. 8.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-30 1,574,769 4,310,325 36.53
2025-05-29 818,855 5,768,675 14.19
2025-05-28 1,138,844 7,038,918 16.18
2025-05-27 894,721 3,948,542 22.66

(click for more detail)

Similar Companies
JNJ – Johnson & Johnson LLY – Eli Lilly and Company
MRK – Merck & Co., Inc. OGN – Organon & Co.
PBH – Prestige Consumer Healthcare Inc.


Financial data and stock pages provided by
Fintel.io